CORRECTING and REPLACING Synergy Laboratories Adds to Its Arsenal of COVID-19 Diagnostic Tools

Please replace the release with the following corrected version due to multiple revisions.

The corrected release reads:

SYNERGY LABORATORIES ADDS TO ITS ARSENAL OF COVID-19 DIAGNOSTIC TOOLS

Synergy Laboratories (Synergy) is adding a new testing platform to augment its vital COVID-19 diagnostic capabilities. The new platform will more than double Synergy’s Reverse Transcription - Polymerase Chain Reaction (RT-PCR) testing capability to approximately 2,500 tests per day while integrating seamlessly with Synergy’s already robust testing regimen which is serving first line responders, healthcare providers, hospitals, clinics and nursing homes all across the Gulf Coast and throughout the State of Alabama.

"Synergy was one of the first medical laboratories in South Alabama to offer FDA approved testing for the COVID-19 virus and this addition to our diagnostic toolbox will help us continue our leadership role in the pandemic fight. The need for fast, accurate testing is crucial to ensuring the safety of the public and we believe our additional testing capabilities will provide public health officials and healthcare providers with key information to help control the spread of this potentially deadly virus," said Brad Pitts, Synergy’s Chief Executive Officer.

The new testing capability will utilize a Roche cobas® 6800 molecular testing unit that uses Nobel-prize winning PCR technology in a highly automated environment to provide accurate results in a minimal amount of time. This will enable public health officials to identify potential viral hotspots sooner and will give healthcare providers the information they need faster than ever before.

Brandon Biles, Synergy’s Chief Operating Officer, said the decision to add additional FDA-approved testing capabilities reflects Synergy’s commitment to public health and its support of its partner healthcare facilities and providers. He said, "We have been at the forefront of COVID-19 detection and mitigation efforts and this will allow us to be an even more effective resource for those who are on the front lines combating the virus. Adding another state of the art COVID-19 platform to the Synergy offering will allow Synergy to serve more people across the State of AL and specifically the Gulf Coast."

Synergy is processing Covid 19 samples delivered to the lab from healthcare facilities and physicians’ offices only. Existing Synergy clients may order test kits through their normal online channels. Prospective customers can contact Synergy by phone at (251) 662-9760 or establish a new client relationship through Synergy’s New Client link at www.synergytesting.com.

About Synergy Laboratories

Synergy Laboratories is a full-service diagnostic laboratory that utilizes a wide range of innovative platforms to improve patient care. Founded in 2015, by Brad Pitts and Brandon Biles, Synergy’s mission is to ethically serve the healthcare sector and give healthcare providers quality service and accurate results. In recent years, Synergy has continued to invest in the latest technology to serve their ever-growing client base. This includes many exciting announcements to follow. To learn more, visit www.synergytesting.com or stay up to date with Synergy on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200528005029/en/

Contacts

Barkley Busby
Chief Marketing Officer
barkley.busby@synergytesting.com • (205) 612-3124